152 related articles for article (PubMed ID: 10928951)
1. Disparate ligand-mediated Ca(2+) responses by wild-type, mutant Ser(200)Ala and Ser(204)Ala alpha(2A)-adrenoceptor: G(alpha15) fusion proteins: evidence for multiple ligand-activation binding sites.
Pauwels PJ; Colpaert FC
Br J Pharmacol; 2000 Aug; 130(7):1505-12. PubMed ID: 10928951
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous ligand-mediated Ca(++) responses at wt and mutant alpha(2A)-adrenoceptors suggest multiple ligand activation binding sites at the alpha(2A)-adrenoceptor.
Pauwels PJ; Colpaert FC
Neuropharmacology; 2000 Aug; 39(11):2101-11. PubMed ID: 10963753
[TBL] [Abstract][Full Text] [Related]
3. Analysis of ligand activation of alpha 2-adrenoceptor subtypes under conditions of equal G alpha protein stoichiometry.
Pauwels PJ; Wurch T; Tardif S; Finana F; Colpaert FC
Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):526-36. PubMed ID: 11383713
[TBL] [Abstract][Full Text] [Related]
4. Partial to complete antagonism by putative antagonists at the wild-type alpha(2C)-adrenoceptor based on kinetic analyses of agonist:antagonist interactions.
Pauwels PJ; Colpaert FC
Br J Pharmacol; 2000 Dec; 131(7):1385-90. PubMed ID: 11090111
[TBL] [Abstract][Full Text] [Related]
5. Enhanced stability of wild-type and constitutively active alpha(2A)-adrenoceptors by ligands with agonist, silent and inverse agonist properties.
Pauwels PJ; Tardif S
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):134-41. PubMed ID: 12122500
[TBL] [Abstract][Full Text] [Related]
6. Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and g(alphao) protein coexpression: evidence for inverse agonism.
Pauwels PJ; Tardif S; Wurch T; Colpaert FC
J Pharmacol Exp Ther; 2000 Feb; 292(2):654-63. PubMed ID: 10640303
[TBL] [Abstract][Full Text] [Related]
7. Modulation of ligand responses by coupling of alpha(2A)-adrenoceptors to diverse G(alpha)-proteins.
Pauwels PJ; Tardif S; Colpaert FC; Wurch T
Biochem Pharmacol; 2001 May; 61(9):1079-92. PubMed ID: 11301041
[TBL] [Abstract][Full Text] [Related]
8. Ligand-receptor interactions as controlled by wild-type and mutant Thr(370)Lys alpha2B-adrenoceptor-Galpha15 fusion proteins.
Pauwels PJ; Tardif S; Finana F; Wurch T; Colpaert FC
J Neurochem; 2000 Jan; 74(1):375-84. PubMed ID: 10617142
[TBL] [Abstract][Full Text] [Related]
9. Dissimilar pharmacological responses by a new series of imidazoline derivatives at precoupled and ligand-activated alpha 2A-adrenoceptor states: evidence for effector pathway-dependent differential antagonism.
Pauwels PJ; Rauly I; Wurch T
J Pharmacol Exp Ther; 2003 Jun; 305(3):1015-23. PubMed ID: 12649300
[TBL] [Abstract][Full Text] [Related]
10. Agonist efficacy at the alpha2A-adrenoceptor:G alpha15 fusion protein: an analysis based on Ca2+ responses.
Pauwels PJ; Finana F; Tardif S; Colpaert FC; Wurch T
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):672-9. PubMed ID: 10882043
[TBL] [Abstract][Full Text] [Related]
11. G-protein activation by putative antagonists at mutant Thr373Lys alpha2A adrenergic receptors.
Wurch T; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1999 Feb; 126(4):939-48. PubMed ID: 10193774
[TBL] [Abstract][Full Text] [Related]
12. Evidence for protean agonism of RX 831003 at alpha 2A-adrenoceptors by co-expression with different G alpha protein subunits.
Pauwels PJ; Rauly I; Wurch T; Colpaert FC
Neuropharmacology; 2002 May; 42(6):855-63. PubMed ID: 12015212
[TBL] [Abstract][Full Text] [Related]
13. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
[TBL] [Abstract][Full Text] [Related]
14. Agonist-directed trafficking of porcine alpha(2A)-adrenergic receptor signaling in Chinese hamster ovary cells: l-isoproterenol selectively activates G(s).
Brink CB; Wade SM; Neubig RR
J Pharmacol Exp Ther; 2000 Aug; 294(2):539-47. PubMed ID: 10900230
[TBL] [Abstract][Full Text] [Related]
15. S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine.
Millan MJ; Dekeyne A; Newman-Tancredi A; Cussac D; Audinot V; Milligan G; Duqueyroix D; Girardon S; Mullot J; Boutin JA; Nicolas JP; Renouard-Try A; Lacoste JM; Cordi A
J Pharmacol Exp Ther; 2000 Dec; 295(3):1192-205. PubMed ID: 11082457
[TBL] [Abstract][Full Text] [Related]
16. Mutation in a protein kinase C phosphorylation site of the 5-HT1A receptor preferentially attenuates Ca2+ responses to partial as opposed to higher-efficacy 5-HT1A agonists.
Wurch T; Colpaert FC; Pauwels PJ
Neuropharmacology; 2003 Jun; 44(7):873-81. PubMed ID: 12726819
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal modulation of alpha(2A)-adrenoceptor and G(alpha o) protein states as determined by carboxy-terminal mutagenesis of a G(alpha o) protein.
Wurch T; Okuda J; Pauwels PJ
Mol Pharmacol; 2001 Oct; 60(4):666-73. PubMed ID: 11562427
[TBL] [Abstract][Full Text] [Related]
18. Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: cellular and functional characterization.
Millan MJ; Cussac D; Milligan G; Carr C; Audinot V; Gobert A; Lejeune F; Rivet JM; Brocco M; Duqueyroix D; Nicolas JP; Boutin JA; Newman-Tancredi A
J Pharmacol Exp Ther; 2001 Jun; 297(3):876-87. PubMed ID: 11356907
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human recombinant alpha(2A)-adrenoceptors expressed in Chinese hamster lung cells using intracellular Ca(2+) changes: evidence for cross-talk between recombinant alpha(2A)- and native alpha(1)-adrenoceptors.
Reynen PH; Martin GR; Eglen RM; MacLennan SJ
Br J Pharmacol; 2000 Apr; 129(7):1339-46. PubMed ID: 10742289
[TBL] [Abstract][Full Text] [Related]
20. Ligand recognition of serine-cysteine amino acid exchanges in transmembrane domain 5 of alpha2-adrenergic receptors by UK 14,304.
Cockcroft V; Frang H; Pihlavisto M; Marjamäki A; Scheinin M
J Neurochem; 2000 Apr; 74(4):1705-10. PubMed ID: 10737629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
